drugset / Trial / NCT00143806
Transitioning From Cyclosporine to Alefacept in Psoriasis
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to devise a safe and effective method for transitioning patients from cyclosporine to alefacept.
Timeline
- Start
- 2003-10
- Primary completion
- —
- Completion
- 2007-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Alefacept | Protein / enzyme biologic | — | — |
| Subject | Cyclosporine | Peptide | — | — |